Search for Clinical Trial Results

Sponsored By

Plasmacytoma - 153 Studies Found

Status Study
Active, not recruiting Study Name: Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-10-12
Interventions:
  • Drug: dexamethasone

Active, not recruiting Study Name: High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-09-04
Interventions:
  • Drug: cyclophosphamide Given o
Terminated Study Name: Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-08-29
Interventions:
  • Drug: bortezomib Intravenous P
Terminated Study Name: Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-08-26
Interventions:
  • Drug: bortezomib
  • Drug: dexamethasone
Terminated Study Name: Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-05-30
Interventions:
  • Drug: dexamethasone 20 mg oral
Terminated Study Name: High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-03-14
Interventions:
  • Drug: melphalan
  • Procedure: autologous hema
Completed Study Name: Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-03-12
Interventions:
  • Biological: Anakinra (IL-1Ra)

Terminated Study Name: Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-03-12
Interventions:
  • Biological: anti-thymocyte globulin

Completed Study Name: Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-02-19
Interventions:
  • Drug: everolimus
  • Genetic: DNA analysis
Completed Study Name: Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Date: 2008-02-14
Interventions:
  • Biological: aldesleukin
  • Biological: idioty
<<< Previous | Next >>>